Log In
BCIQ
Print this Print this
 

Moxatag (Amoxicillin Pulsys) (APC-111)

  Manage Alerts
Collapse Summary General Information
Company Vernalis plc
DescriptionPulsatile-release formulation of amoxicillin
Molecular Target Penicillin binding proteins (PBP)
Mechanism of ActionCell wall synthesis inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationStreptococcus
Indication DetailsTreat acute pediatric tonsillitis/pharyngitis in children due to group A Streptococcus infections; Treat tonsillitis/pharyngitis due to group A Streptococcus infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$144.1M

$135.1M

$9.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today